Antonijevic Irina 4
4 · Biohaven Ltd. · Filed Dec 29, 2023
Insider Transaction Report
Form 4
Biohaven Ltd.BHVN
Antonijevic Irina
Director
Transactions
- Exercise/Conversion
Common Shares
2023-12-29+11,000→ 13,535 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-12-29−11,000→ 114,000 totalExercise: $7.00Exp: 2032-10-03→ Common Shares (11,000 underlying) - Sale
Common Shares
2023-12-29$41.79/sh−11,000$459,663→ 2,535 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.74 - $41.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date.